Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Anna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
Yifang Tang, Zheng-hua Liu, Lei-yi Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
Subhadeep Das, Shayak Samaddar
Cancers (2025) Vol. 17, Iss. 2, pp. 255-255
Open Access
Deep analysis of the trials and major challenges in the first-line treatment for patients with extensive-stage small cell lung cancer
Ran Gao, Peizhu Wu, Xiaoyan Yin, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114116-114116
Open Access
Promotion Mechanisms of Stromal Cell-Mediated Lung Cancer Development Within Tumor Microenvironment
Siyu Wu, Yumeng Hu, Bowen Sui
Cancer Management and Research (2025) Vol. Volume 17, pp. 249-266
Open Access
Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer
Kristóf Csende, Bence Ferencz, Kristiina Boettiger, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104514-104514
Closed Access
Prognostic significance of ALK high expression in SCLC: a 9-year cohort analysis
Jinhe Xu, Wenting Zhang, Feilai Xie, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation
Anna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Imbalance of B-Cell Subpopulations in the Microenvironment of Sarcoidosis or Lung Cancer
Agata Raniszewska, Iwona Kwiecień, Elżbieta Rutkowska, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1274-1274
Open Access | Times Cited: 1
Immunotherapy for small cell lung cancer: the current state and future trajectories
Min Qiang, Hongyang Liu, Lei Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells
David Sadava, Shiuan Chen
Cancers (2024) Vol. 16, Iss. 22, pp. 3812-3812
Open Access | Times Cited: 1
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes
Veronika Pozonec, Maria Dorothea Pozonec, Clemens Aigner, et al.
Current Opinion in Oncology (2024) Vol. 37, Iss. 1, pp. 27-34
Open Access | Times Cited: 1
Nucleic acid-sensing-related gene signature in predicting prognosis and treatment efficiency of small cell lung cancer patients
Qianshi Liu, Zhaoshen Li, Na Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top